Pralidoxime Comparative Effectiveness
Pralidoxime Comparative Effectiveness is a research construct in clinical pharmacology that evaluates the relative therapeutic outcomes of pralidoxime against alternative or adjunctive treatments for organophosphate poisoning, distinguished by its focus on efficacy, safety, and clinical utility across different dosing regimens, patient populations, and毒ological contexts.
8
Publications
401
Citations
38
Authors
17
Institutions
Publications per year
2017–2026
0
Parents
8
Pralidoxime in Acute Organophosphorus Insecticide Poisoning—A Randomised Controlled Trial
Michael Eddleston, Peter Eyer, Franz Worek et al. · PLoS Medicine · 2009 · 169 citations · Full text
Tariq Wani, Sumaya Syed, Showkat Ahmad Gurcoo et al. · Saudi Journal of Anaesthesia · 2014 · 29 citations · Full text
1–5 of 8
38
3
h-index
3
h-index
2
h-index
2
h-index
United Arab Emirates University, United Arab Emirates
2 publications · 82 citations
2
h-index
1–5 of 38
17
United Arab Emirates University
Al Ain, United Arab Emirates
3 h-index
14 publications
448 citations
Christian Medical College, Vellore
Vellore, India
1 h-index
1 publications
42 citations
University of Oxford
Oxford, United Kingdom
1 h-index
3 publications
507 citations

UNSW Sydney
Sydney, Australia
1 h-index
1 publications
169 citations
University of Newcastle Australia
Newcastle, Australia
1 h-index
1 publications
169 citations
University of Defence
Brno, Czechia
1 h-index
2 publications
112 citations
South Asian Clinical Toxicology Research Collaboration
Kandy, Sri Lanka
1 h-index
6 publications
1K citations
Yuxian People's Hospital
Yuzhou, China
1 h-index
1 publications
10 citations
1–8 of 17
Repository · 2 publications · 52 citations
2
h-index
2 publications · 76 citations
2
h-index
1 publications · 49 citations
1
h-index
1 publications · 29 citations
1
h-index
1 publications · 26 citations
1
h-index
1–5